← Open Payments lookup

HILARY UGRAS: Open Payments

NPI 1083099840 · BOSTON, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$13,158 in 29 payments from 6 companies in 2025. Trend: 2023 $154 · 2024 $4,927 · 2025 $13,158

Consulting: $5,685Speaker / faculty: $5,548Travel & lodging: $1,173Food & beverage: $752
CompanyPaymentsAmount
GENZYME CORPORATION5$5,884
Regeneron Healthcare Solutions, Inc.16$4,367
Regeneron Pharmaceuticals, Inc.3$1,494
Takeda Pharmaceuticals U.S.A., Inc.1$1,084
Phathom Pharmaceuticals, Inc.3$222
Ipsen Biopharmaceuticals, Inc1$107

Products named: DUPIXENT, EOHILIA, VOQUEZNA, Bylvay.

Industry payments across MA — which companies pay providers there.